Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

Unlike President Trump's picks to lead other health agencies who established their conservative bona fides during the ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...

During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...

This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...